Injectsense
Stephen Sinclair, MD, FAAO, owns and directs Sinclair Retinal Associates, a premier practice group that specializes in all types of surgical, medical and laser treatment of the retina and vitreous. He is also CEO of the ophthalmologic device and drug development company Sinclair Technologies and CEO of the non-profit Clear Vision Foundation. He is Adjunct Professor of Ophthalmology at Drexel University School of Medicine, Philadelphia.
This person is not in the org chart
This person is not in any offices
Injectsense
Injectsense enables tracking of progressive disease indicators and improved therapy management by providing continuous, clinically actionable information through an injectable ultra-miniature sensor coupled with a secure digital health platform.